Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Poly Medicure Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹1,346.90Fairly Valued by 4.98%vs CMP ₹1,283.00

P/E (36.9) × ROE (15.8%) × BV (₹288.00) × DY (0.27%)

₹701.80Overvalued by 45.30%vs CMP ₹1,283.00
MoS: -82.8% (Negative)Confidence: 63/100 (Moderate)Models: 1 Under, 8 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹1,583.4223%Under (+23.4%)
Graham NumberEarnings₹471.5217%Over (-63.2%)
Earnings PowerEarnings₹188.6911%Over (-85.3%)
DCFCash Flow₹743.9011%Over (-42%)
Net Asset ValueAssets₹287.957%Over (-77.6%)
EV/EBITDAEnterprise₹613.199%Over (-52.2%)
Earnings YieldEarnings₹343.107%Over (-73.3%)
ROCE CapitalReturns₹457.059%Over (-64.4%)
Revenue MultipleRevenue₹246.966%Over (-80.8%)
Consensus (9 models)₹701.80100%Overvalued
Key Drivers: Wide model spread (₹189–₹1,583) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 17.6%

*Investments are subject to market risks

Analyst Summary

Poly Medicure Ltd operates in the Medical Equipment & Accessories segment, NSE: POLYMED | BSE: 531768, current market price is ₹1,283.00, market cap is 13,006 Cr.. At a glance, stock P/E is 36.9, ROE is 15.8 %, ROCE is 20.1 %, book value is 288, dividend yield is 0.27 %. The latest intrinsic value estimate is ₹701.80, around 45.3% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹1,669 Cr versus the prior period change of 21.4%, while latest net profit is about ₹339 Cr with a prior-period change of 31.4%. The 52-week range shown on this page is 2,938/1,182, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisPoly Medicure Ltd. is a Public Limited Listed company incorporated on 30/03/1995 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L40300DL1…

This summary is generated from the stock page data available for Poly Medicure Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

69
Poly Medicure Ltd scores 69/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health83/100 · Strong
ROCE 20.1% ExcellentROE 15.8% GoodD/E 0.10 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money45/100 · Moderate
FII holding down -2.05% (6mo) SellingDII holding up 1.88% MF buyingPromoter holding at 62.4% Stable
Earnings Quality65/100 · Strong
OPM expanding (24% → 27%) Improving
Quarterly Momentum58/100 · Moderate
Revenue (4Q): +11% YoY GrowingProfit (4Q): +11% YoY PositiveOPM: 23.0% (down 4.0% YoY) Margin pressure
Industry Rank75/100 · Strong
P/E 36.9 vs industry 21.1 Premium to peersROCE 20.1% vs industry 13.2% Above peersROE 15.8% vs industry 10.4% Above peers3Y sales CAGR: 22% High growth

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:29 am

Market Cap 13,006 Cr.
Current Price 1,283
Intrinsic Value₹701.80
High / Low 2,938/1,182
Stock P/E36.9
Book Value 288
Dividend Yield0.27 %
ROCE20.1 %
ROE15.8 %
Face Value 5.00
PEG Ratio2.10

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Poly Medicure Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Poly Medicure Ltd 13,006 Cr. 1,283 2,938/1,18236.9 2880.27 %20.1 %15.8 % 5.00
Mohini Health & Hygiene Ltd 67.9 Cr. 37.2 66.0/33.120.3 55.70.00 %14.1 %10.0 % 10.0
Constronics Infra Ltd 58.9 Cr. 47.0 75.2/40.715.2 32.80.00 %19.7 %15.8 % 10.0
Adeshwar Meditex Ltd 24.5 Cr. 17.0 21.8/13.311.8 26.10.00 %8.27 %5.51 % 10.0
Centenial Surgical Suture Ltd 28.1 Cr. 77.0 189/76.3 84.10.00 %3.94 %4.64 % 10.0
Industry Average13,006.00 Cr292.2421.0597.340.05%13.22%10.35%9.00

All Competitor Stocks of Poly Medicure Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 285307321337340378385420424441403444494
Expenses 214224234253249282281305310321298329382
Operating Profit 718387849096104115114119106115111
OPM % 25%27%27%25%27%26%27%27%27%27%26%26%23%
Other Income 1591415171517272427433521
Interest 5222333332336
Depreciation 14151616161620212121232529
Profit before tax 6775838188929811811312312312298
Tax % 25%22%24%23%26%26%25%26%25%25%24%25%27%
Net Profit 50596362656874878592939271
EPS in Rs 5.216.136.546.486.787.127.718.638.419.069.199.067.00

Last Updated: March 3, 2026, 3:45 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 9:46 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 3223904114545196106877859221,1151,3751,6691,782
Expenses 2463043233613974795205697078471,0141,2141,331
Operating Profit 76868893122131166216215267361455451
OPM % 24%22%21%21%23%22%24%28%23%24%26%27%25%
Other Income 11288141620212240386094126
Interest 91010812142011611141414
Depreciation 14192124293741485457638398
Profit before tax 6385657597100126180195237344453465
Tax % 30%27%27%27%27%35%24%25%25%25%25%25%
Net Profit 45624855716596136147179258339348
EPS in Rs 5.117.075.476.258.007.4110.8614.1715.2818.6926.9133.4134.31
Dividend Payout % 20%18%27%40%25%27%18%18%16%16%11%10%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)37.78%-22.58%14.58%29.09%-8.45%47.69%41.67%8.09%21.77%44.13%31.40%
Change in YoY Net Profit Growth (%)0.00%-60.36%37.16%14.51%-37.54%56.14%-6.03%-33.58%13.68%22.37%-12.74%

Poly Medicure Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:16%
5 Years:19%
3 Years:22%
TTM:17%
Compounded Profit Growth
10 Years:22%
5 Years:29%
3 Years:34%
TTM:33%
Stock Price CAGR
10 Years:27%
5 Years:35%
3 Years:33%
1 Year:-21%
Return on Equity
10 Years:17%
5 Years:16%
3 Years:17%
Last Year:16%

Last Updated: September 5, 2025, 12:20 pm

Balance Sheet

Last Updated: December 4, 2025, 1:48 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 22222244444444484848485151
Reserves 1241742072272943373919181,0401,1941,4222,7152,868
Borrowings 677982101133161207137127149174180240
Other Liabilities 7389768594112126121163187215246429
Total Liabilities 2863643874575656547671,2241,3771,5771,8593,1923,587
Fixed Assets 1231651822072653063634264886358671,0841,439
CWIP 201014201819252143787610183
Investments 3443178253543461261671,077930
Other Assets 1401851872272643213544224997387489301,135
Total Assets 2863643874575656547671,2241,3771,5771,8593,1923,587

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 6663635675106131119123191266240
Cash from Investing Activity + -58-59-31-56-88-101-109-436-85-179-241-1,194
Cash from Financing Activity + 5-6-31-016-5-21317-35-13-20951
Net Cash Flow 13-21031103-15-3
Free Cash Flow 81331-0-7312524-31-48-9-89
CFO/OP 111%101%88%79%80%102%100%75%80%93%94%73%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow9.007.006.00-8.00-11.00-30.00-41.0079.0088.00118.00187.00275.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 525974777977687282777276
Inventory Days 142148114194161186241217218237205233
Days Payable 10110176131961231421111151058971
Cash Conversion Cycle 94106111140144139166179185209188239
Working Capital Days 202535557156447481695474
ROCE %33%30%26%24%26%22%25%22%17%18%24%20%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 53.32%53.32%53.17%53.17%53.14%66.02%62.56%62.44%62.44%62.44%62.42%62.42%
FIIs 16.21%15.61%14.49%14.10%12.37%9.91%11.88%12.33%11.46%11.41%9.77%9.41%
DIIs 3.67%4.25%5.15%5.46%7.21%9.34%12.33%11.66%11.96%11.72%13.53%13.84%
Public 26.79%26.82%27.20%27.28%27.25%14.72%13.23%13.57%14.13%14.43%14.28%14.34%
No. of Shareholders 35,39336,14134,64936,05336,71236,85238,35260,68665,58371,14264,40067,750

Shareholding Pattern Chart

No. of Shareholders

Poly Medicure Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Quant Small Cap Fund 4,357,016 2.42 662.663,457,0162026-02-23 05:30:2626.03%
UTI Flexi Cap Fund 1,381,500 0.89 210.112,144,7732025-12-08 04:07:55-35.59%
SBI Healthcare Opportunities Fund 640,000 2.55 97.34600,0002026-02-23 05:17:246.67%
SBI MNC Fund 560,000 1.52 85.17500,0002026-02-22 00:41:4912%
WhiteOak Capital Flexi Cap Fund 331,163 0.71 50.37314,3112025-12-15 02:14:185.36%
Quant Multi Cap Fund 264,798 0.54 40.27N/AN/AN/A
Invesco India Largecap Fund 173,600 1.58 26.4164,0032025-12-15 02:38:255.85%
WhiteOak Capital Mid Cap Fund 155,414 0.53 23.6451,9062025-12-08 04:07:55199.41%
WhiteOak Capital Multi Cap Fund 146,104 0.74 22.22N/AN/AN/A
Whiteoak Capital Large & Mid Cap Fund 59,294 0.44 9.02N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 5.005.005.005.005.00
Basic EPS (Rs.) 34.1326.9218.6915.2815.25
Diluted EPS (Rs.) 34.1126.9018.6715.2715.24
Cash EPS (Rs.) 41.0633.3124.4420.6518.78
Book Value[Excl.RevalReserv]/Share (Rs.) 272.95153.18129.41113.40100.71
Book Value[Incl.RevalReserv]/Share (Rs.) 272.95153.18129.41113.40100.71
Revenue From Operations / Share (Rs.) 164.80143.35116.2496.2582.03
PBDIT / Share (Rs.) 53.4943.4531.4326.1724.28
PBIT / Share (Rs.) 45.3336.7925.4720.5519.32
PBT / Share (Rs.) 44.1535.6124.5520.1018.43
Net Profit / Share (Rs.) 32.9026.6518.4815.0213.83
NP After MI And SOA / Share (Rs.) 33.4126.9118.6915.2814.17
PBDIT Margin (%) 32.4530.3027.0427.1929.59
PBIT Margin (%) 27.5025.6621.9121.3423.55
PBT Margin (%) 26.7824.8321.1220.8822.47
Net Profit Margin (%) 19.9618.5815.9015.6016.85
NP After MI And SOA Margin (%) 20.2718.7716.0715.8717.27
Return on Networth / Equity (%) 12.2417.5614.4313.4714.07
Return on Capital Employeed (%) 16.2723.4219.0317.1317.60
Return On Assets (%) 10.6013.8911.3610.6411.10
Long Term Debt / Equity (X) 0.000.000.010.030.06
Total Debt / Equity (X) 0.060.110.110.110.10
Asset Turnover Ratio (%) 0.660.800.730.680.76
Current Ratio (X) 5.182.402.753.464.12
Quick Ratio (X) 4.411.772.042.713.38
Inventory Turnover Ratio (X) 6.592.162.252.392.22
Dividend Payout Ratio (NP) (%) 8.9711.1413.3716.360.00
Dividend Payout Ratio (CP) (%) 7.218.9310.1411.950.00
Earning Retention Ratio (%) 91.0388.8686.6383.640.00
Cash Earning Retention Ratio (%) 92.7991.0789.8688.050.00
Interest Coverage Ratio (X) 45.1836.9034.1258.9927.35
Interest Coverage Ratio (Post Tax) (X) 28.7923.6321.0734.8616.57
Enterprise Value (Cr.) 22744.5615271.329107.859208.877911.73
EV / Net Operating Revenue (X) 13.6211.108.179.9810.06
EV / EBITDA (X) 41.9736.6230.2036.6933.99
MarketCap / Net Operating Revenue (X) 13.6111.088.209.869.97
Retention Ratios (%) 91.0288.8586.6283.630.00
Price / BV (X) 8.2110.377.368.378.12
Price / Net Operating Revenue (X) 13.6111.088.209.869.97
EarningsYield 0.010.010.010.010.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Poly Medicure Ltd. is a Public Limited Listed company incorporated on 30/03/1995 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L40300DL1995PLC066923 and registration number is 066923. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 1601.80 Cr. and Equity Capital is Rs. 50.66 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Medical Equipment & AccessoriesNo. 232-B, 3rd Floor, New Delhi Delhi 110020Contact not found
Management
NamePosition Held
Mr. Devendra Raj MehtaChairman (Non - Executive) & Non Independent Direc
Mr. Himanshu BaidManaging Director
Mr. Rishi BaidJoint Managing Director
Mr. Vishal BaidExecutive Director
Mr. Jugal Kishore BaidNon Exe.Non Ind.Director
Mr. Alessandro BalboniNon Exe.Non Ind.Director
Dr. Ambrish MithalInd. Non-Executive Director
Mr. Vimal BhandariInd. Non-Executive Director
Mr. Amit KhoslaInd. Non-Executive Director
Ms. Sonal MattooInd. Non-Executive Director
Mr. Vishal GuptaInd. Non-Executive Director
Mr. Pankaj Kumar GuptaAdditional Executive Director

FAQ

What is the intrinsic value of Poly Medicure Ltd and is it undervalued?

As of 23 April 2026, Poly Medicure Ltd's intrinsic value is ₹701.80, which is 45.30% lower than the current market price of ₹1,283.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (15.8 %), book value (₹288), dividend yield (0.27 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Poly Medicure Ltd?

Poly Medicure Ltd is trading at ₹1,283.00 as of 23 April 2026, with a FY2026-2027 high of ₹2,938 and low of ₹1,182. The stock is currently near its 52-week low. Market cap stands at ₹13,006 Cr..

How does Poly Medicure Ltd's P/E ratio compare to its industry?

Poly Medicure Ltd has a P/E ratio of 36.9, which is above the industry average of 21.05. The premium over industry average may reflect growth expectations or speculative interest.

Is Poly Medicure Ltd financially healthy?

Key indicators for Poly Medicure Ltd: ROCE of 20.1 % indicates efficient capital utilization; ROE of 15.8 % shows strong shareholder returns. Dividend yield is 0.27 %.

Is Poly Medicure Ltd profitable and how is the profit trend?

Poly Medicure Ltd reported a net profit of ₹339 Cr in Mar 2025 on revenue of ₹1,669 Cr. Compared to ₹147 Cr in Mar 2022, the net profit shows an improving trend.

Does Poly Medicure Ltd pay dividends?

Poly Medicure Ltd has a dividend yield of 0.27 % at the current price of ₹1,283.00. The company pays dividends, though the yield is modest.

Last Updated: April 2, 2026, 3:29 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 531768 | NSE: POLYMED
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Poly Medicure Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports